Seeking a share of the first-line…
Seeking a share of the first-line diffuse B-cell lymphoma market, [...]
Seeking a share of the first-line diffuse B-cell lymphoma market, [...]
The German biotech shared updated data from a phase 1 [...]
Nine years after wowing the audience at the American Society [...]
AstraZeneca has shared data it believes can rescue anselamimab from [...]
Agios Pharmaceuticals’ next-gen pyruvate kinase (PK) activator has failed a [...]
Senior Writer Darren Incorvaia talks with industry leaders and experts [...]
Pharma companies need to strengthen and modernize patient support programs [...]
Philips has integrated animated Disney characters and stories into MRI [...]
Pfizer is paying Innovent $650 million upfront to partner on [...]
With a pediatric approval in hand for Afrezza, MannKind may [...]